2022 Annual Meeting - Overview of ASTRO's Radiation Therapy for Endometrial Cancer Guideline: A Multidisciplinary Case-based Interactive Discussion

This session will highlight the contents of the new Endometrial Guideline which addresses important updates in the adjuvant management of non-metastatic endometrial cancer. This will be an interactive multidisciplinary case-based session which will emphasize key recommendations of the guideline, best illustrated through presentation of complex, nuanced and even controversial cases, supported by the literature gathered in the guideline. The audience will be polled during the case presentations and areas of agreement and controversy will be addressed by the expert guideline panel with audience interaction. In addition, SA-CME questions will be provided to confirm comprehension of the guideline information presented during this session.

Target Audience

The activity is designed to meet the interests of radiation oncologists, medical oncologists, radiation physicists, surgeons, pathologists and radiation oncology residents.

Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Analyze recent trials across risk groups and stages of endometrial cancer which have informed on the role of adjuvant RT and systemic therapy.
    • Assess trials on the accuracy of evolving surgical staging techniques (like sentinel lymph node mapping and pathologic ultra-staging) which impact adjuvant therapy decisions.
    • Address the evolving data on the prognostic and predictive use of molecular profiling and its impact on adjuvant treatment selections.

     

    Course summary
    Available credit: 
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Course opens: 
    10/23/2022
    Course expires: 
    12/01/2022
    Cost:
    $0.00
    Rating: 
    0

    Beth Erickson, MD is employed at Department of Radiation Oncology, Froedtert & the Medical College of Wisconsin, Milwaukee, WI and has no financial relationships with a commercial interest.

    Matthew Harkenrider, MD is employed at Loyola University Chicago, Loyola University Medical Center and Edward Hines Jr., VA Hospital, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL and has no financial relationships with a commercial interest.

    Lara Hathout, MD is employed at Rutgers Cancer Institute of New Jersey, New Brunswick, NJ and has no financial relationships with a commercial interest.

    Kathy Han, MD is employed at Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada and receives compensation/remuneration/funding from AstraXeneca and Elelkta MRL Breast TSG.

    Paola Gehrig, MD is employed at University of North Carolina, Chapel Hill, NC and has no financial relationships with a commercial interest.

    Nadeem Abu-Rustum, MD is employed at Memorial Sloan Kettering Cancer Center, New York, NY and has no financial relationships with a commercial interest.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    Policies: 
        • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
        • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
        • ASTRO staff cannot make modifications to your submitted materials.
     

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.